Will OpenEvidence and Johns Hopkins Medicine detail their AI collaboration roadmap by 28 October 2026?
Posted 2026-10-14 — 14 days before the deadline, stated before the outcome.
OpenEvidence is an artificial intelligence platform designed to assist healthcare professionals with clinical decision-making and medical education. Johns Hopkins Medicine is a major academic medical center known for its research and patient care. This forecast concerns the public release of a specific operational plan for their joint initiative.
The claim
OpenEvidence and Johns Hopkins Medicine will finalize and publicly detail the specific operational roadmap for their AI-driven medical education and clinical care collaboration within 14 days.
Reasoning trace
- The initial announcement was a 'landmark collaboration' which typically requires immediate follow-up to define scope.
- Business Wire announcements usually precede a detailed Q&A or roadmap release within days to manage stakeholder expectations.
Evidence so far
0 confirming · 0 denying signals · 2 verified · 1 broken assumptions. The evidence itself is part of the full dossier.
Probability history
Updated 1 time since mint (last on 2026-10-14) — 78% at mint → 82% today.
What to watch
- milestone OpenEvidence and Johns Hopkins Medicine issue a joint press release or announcement confirming the collaboration partnership observed
- milestone OpenEvidence and Johns Hopkins Medicine jointly announce or confirm a signed collaboration agreement or memorandum of understanding (MOU) that is publicly disclosed observed
- milestone OpenEvidence and Johns Hopkins Medicine issue a joint press release or official announcement confirming the collaboration and its general scope (e.g., via Business Wire, hospital newsroom, or company website). observed
The full dossier behind this prediction — the evidence trail, the risk analysis, the monetization scenarios — is available on request: [email protected].
Probabilities are calibrated against the system's own resolved history; after the deadline the outcome is resolved and audited — including the calls we get wrong. Nothing on this page is investment advice.